Benefit of lymph node dissection for perihilar and distal cholangiocarcinoma according to lymph node stations
Journal of Hepato-Biliary-Pancreatic Sciences · 2024
DOI: 10.1002/jhbp.1387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2024. Verfasst von Fumihiro Terasaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Lymph Node Excision, Cholangiocarcinoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
The benefits of lymph node (LN) dissection at each station have not previously been fully investigated in perihilar cholangiocarcinoma (PHCC) and distal cholangiocarcinoma (DCC).
Methods
The efficacy index (EI) was calculated in patients who underwent surgery for PHCC ( n = 134) and DCC ( n = 135) by multiplying the frequency of metastasis to the LN station and the 5‐year overall survival (OS) rate of patients with metastasis to that station.
Results
In PHCC, the frequency of metastasis, 5‐year OS rates, and the EI in para‐aortic LNs (4.7%, 0%, and 0, respectively) and posterior pancreaticoduodenal LNs (8.1%, 0%, and 0, respectively) were lower than those in hepatoduodenal ligament LNs (30.1%, 24.1%, and 7.25, respectively) and LNs along the common hepatic artery (CHA) (16.2%, 15.0%, and 2.43, respectively). In DCC, these values were lower in LNs along the CHA (6.4%, 0%, and 0, respectively) than in the posterior pancreaticoduodenal LNs (31.2%, 34.5%, and 10.8, respectively), the hepatoduodenal ligament LNs (14.8%, 15.2%, and 2.25, respectively), and para‐aortic (4.0%, 25.0%, and 0.99, respectively) LNs.
Conclusions
According to the EI, this study raises concerns about the effectiveness of dissection in the posterior pancreaticoduodenal LNs in PHCC and LNs along the CHA in DCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
ORCID-Profile: Fumihiro Terasaki, Teiichi Sugiura, Yukiyasu Okamura, Ryo Ashida, Mihoko Yamada, Shimpei Ohtsuka, Katsuhiko Uesaka
Zitieren
APA
Terasaki, F., Sugiura, T., Okamura, Y., Ashida, R., Ohgi, K., Yamada, M., Ohtsuka, S., & Uesaka, K. (2024). Benefit of lymph node dissection for perihilar and distal cholangiocarcinoma according to lymph node stations. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.1387
Vancouver
Terasaki F, Sugiura T, Okamura Y, Ashida R, Ohgi K, Yamada M, et al. Benefit of lymph node dissection for perihilar and distal cholangiocarcinoma according to lymph node stations. Journal of Hepato-Biliary-Pancreatic Sciences. 2024. doi:10.1002/jhbp.1387
BibTeX
@article{Terasaki2024,
author = {Terasaki, Fumihiro and Sugiura, Teiichi and Okamura, Yukiyasu and Ashida, Ryo and Ohgi, Katsuhisa and Yamada, Mihoko and Ohtsuka, Shimpei and Uesaka, Katsuhiko},
title = {Benefit of lymph node dissection for perihilar and distal cholangiocarcinoma according to lymph node stations},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2024},
doi = {10.1002/jhbp.1387}
}
EUVIMED